Smart Drug Development & Design from Candidate to Phase I

Home  >>  Allgemein  >>  Smart Drug Development & Design from Candidate to Phase I

Smart Drug Development & Design from Candidate to Phase I

On April 2, 2019, Posted by , In Allgemein, With Kommentare deaktiviert für Smart Drug Development & Design from Candidate to Phase I

When: April 4 I 9:30am – 2:15pm

Where: Conference Center Technology Park, Im Neuenheimer Feld 582, Heidelberg

This event will focus on key considerations for transitioning a molecule from discovery to phase 1 readiness including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of clinical supply services solutions to meet protocol, clinical site and patient needs.

The program can be downloaded here, and more information are available here!

The event is free of charge but a registration is required.

Following the meeting, all Catalent speakers and executives will be available for private, no-obligation discussions on specific programmes and challenges. To request an appointment, please contact Annalisa Zuccotti (az@biorn.org).

The following two tabs change content below.

Eva

Business Creation Manager bei German EIT Health
Eva-Maria Gottmann is an online communication specialist connecting communication and media skills with entrepreneurship. Eva designed the biotech-entrepreneurship.com website and serves also as editor for the blog.

Neueste Artikel von Eva (alle ansehen)

Comments are closed.